Advanced BRAFV600 Wild-type Melanoma
1 clinical trials · Condition
◉ Watch Advanced BRAFV600 Wild-type Melanoma
| Record | Firm | Date |
|---|---|---|
| A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma (NCT03273153) | Hoffmann-La Roche | 2017-12-11 |
Track Advanced BRAFV600 Wild-type Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.